Browse by People

Collapse authors list.
Wilson, Brooke E ORCID: 0000-0001-6557-7298, Armstrong, Andrew J ORCID: 0000-0001-7012-1754, de Bono, Johann ORCID: 0000-0002-2034-595X, Sternberg, Cora N ORCID: 0000-0003-3938-2627, Ryan, Charles J, Scher, Howard I, Smith, Matthew R, Rathkopf, Dana, Logothetis, Christopher J, Chi, Kim N ORCID: 0000-0002-3782-7226 et al (show 9 more authors) , Jones, Robert J ORCID: 0000-0001-5608-001X, Saad, Fred, De Porre, Peter, Tran, NamPhuong, Hu, Peter, Gillessen, Silke, Carles, Joan ORCID: 0000-0002-9983-5934, Fizazi, Karim and Joshua, Anthony M (2022) Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302. European journal of cancer (Oxford, England : 1990), 170. pp. 296-304.

Collapse authors list.
Gillessen, Silke, Bossi, Alberto, Davis, Ian D, de Bono, Johann ORCID: 0000-0002-2034-595X, Fizazi, Karim, James, Nicholas D ORCID: 0000-0002-7314-8204, Mottet, Nicolas, Shore, Neal, Small, Eric, Smith, Mathew et al (show 108 more authors) , Sweeney, Christopher, Tombal, Bertrand, Antonarakis, Emmanuel S, Aparicio, Ana M, Armstrong, Andrew J, Attard, Gerhardt, Beer, Tomasz M, Beltran, Himisha, Bjartell, Anders, Blanchard, Pierre, Briganti, Alberto, Bristow, Rob G, Bulbul, Muhammad, Caffo, Orazio, Castellano, Daniel, Castro, Elena ORCID: 0000-0002-3691-6454, Cheng, Heather H, Chi, Kim N, Chowdhury, Simon, Clarke, Caroline S, Clarke, Noel, Daugaard, Gedske, De Santis, Maria, Duran, Ignacio, Eeles, Ros, Efstathiou, Eleni, Efstathiou, Jason, Ngozi Ekeke, Onyeanunam, Evans, Christopher P, Fanti, Stefano, Feng, Felix Y, Fonteyne, Valerie, Fossati, Nicola, Frydenberg, Mark, George, Daniel, Gleave, Martin, Gravis, Gwenaelle ORCID: 0000-0002-3127-1554, Halabi, Susan ORCID: 0000-0003-4135-2777, Heinrich, Daniel, Herrmann, Ken, Higano, Celestia, Hofman, Michael S, Horvath, Lisa G, Hussain, Maha, Jereczek-Fossa, Barbara Alicja, Jones, Robert ORCID: 0000-0001-5608-001X, Kanesvaran, Ravindran, Kellokumpu-Lehtinen, Pirkko-Liisa, Khauli, Raja B, Klotz, Laurence, Kramer, Gero, Leibowitz, Raya, Logothetis, Christopher J, Mahal, Brandon A, Maluf, Fernando, Mateo, Joaquin, Matheson, David, Mehra, Niven, Merseburger, Axel, Morgans, Alicia K, Morris, Michael J, Mrabti, Hind, Mukherji, Deborah, Murphy, Declan G, Murthy, Vedang, Nguyen, Paul L, Oh, William K, Ost, Piet, O'Sullivan, Joe M ORCID: 0000-0001-6999-2739, Padhani, Anwar R, Pezaro, Carmel, Poon, Darren MC, Pritchard, Colin C, Rabah, Danny M, Rathkopf, Dana, Reiter, Robert E, Rubin, Mark A, Ryan, Charles J, Saad, Fred, Pablo Sade, Juan, Sartor, Oliver A, Scher, Howard I, Sharifi, Nima, Skoneczna, Iwona, Soule, Howard, Spratt, Daniel E ORCID: 0000-0002-5973-4741, Srinivas, Sandy, Sternberg, Cora N, Steuber, Thomas, Suzuki, Hiroyoshi, Sydes, Matthew R ORCID: 0000-0002-9323-1371, Taplin, Mary-Ellen, Tilki, Derya, Türkeri, Levent, Turco, Fabio, Uemura, Hiroji, Uemura, Hirotsugu, Ürün, Yüksel, Vale, Claire L, van Oort, Inge, Vapiwala, Neha, Walz, Jochen, Yamoah, Kosj, Ye, Dingwei, Yu, Evan Y, Zapatero, Almudena, Zilli, Thomas and Omlin, Aurelius (2023) Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022. , Switzerland.

Collapse authors list.
Banerjee, Susana ORCID: 0000-0002-8840-7934, Michalarea, Vasiliki ORCID: 0000-0002-3102-3534, Ang, Joo Ern ORCID: 0000-0003-2103-996X, Ingles Garces, Alvaro ORCID: 0000-0002-0073-4237, Biondo, Andrea ORCID: 0000-0003-0599-254X, Funingana, Ionut-Gabriel ORCID: 0000-0002-1197-2652, Little, Martin ORCID: 0000-0003-2592-1570, Ruddle, Ruth ORCID: 0000-0003-0025-8872, Raynaud, Florence ORCID: 0000-0003-0957-6279, Riisnaes, Ruth ORCID: 0000-0002-8924-302X et al (show 19 more authors) , Gurel, Bora ORCID: 0000-0002-5018-8078, Chua, Sue ORCID: 0000-0001-5369-8156, Tunariu, Nina ORCID: 0000-0001-6656-3699, Porter, Joanna C ORCID: 0000-0002-7307-169X, Prout, Toby ORCID: 0000-0002-6465-4578, Parmar, Mona ORCID: 0000-0001-7818-4100, Zachariou, Anna ORCID: 0000-0002-7867-8327, Turner, Alison ORCID: 0000-0003-2915-2756, Jenkins, Ben ORCID: 0000-0002-2517-3595, McIntosh, Stuart ORCID: 0000-0002-7379-4505, Ainscow, Ed ORCID: 0000-0002-3119-8422, Minchom, Anna ORCID: 0000-0002-9339-7101, Lopez, Juanita ORCID: 0000-0001-8321-4212, de Bono, Johann ORCID: 0000-0002-2034-595X, Jones, Robert ORCID: 0000-0001-5608-001X, Hall, Emma ORCID: 0000-0001-5999-5020, Cook, Natalie ORCID: 0000-0003-2606-1082, Basu, Bristi ORCID: 0000-0002-3562-2868 and Banerji, Udai ORCID: 0000-0003-1503-3123 (2022) A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 28 (21). pp. 4634-4641.

Collapse authors list.
Scott, Emma, Hodgson, Kirsty, Calle, Beatriz, Turner, Helen, Cheung, Kathleen, Bermudez, Abel, Marques, Fernando Jose Garcia, Pye, Hayley, Yo, Edward Christopher, Islam, Khirul et al (show 49 more authors) , Oo, Htoo Zarni, McClurg, Urszula L ORCID: 0000-0003-2631-4174, Wilson, Laura, Thomas, Huw, Frame, Fiona M, Orozco-Moreno, Margarita, Bastian, Kayla, Arredondo, Hector M, Roustan, Chloe, Gray, Melissa Anne, Kelly, Lois, Tolson, Aaron, Mellor, Ellie, Hysenaj, Gerald, Goode, Emily Archer, Garnham, Rebecca, Duxfield, Adam, Heavey, Susan, Stopka-Farooqui, Urszula, Haider, Aiman, Freeman, Alex, Singh, Saurabh, Johnston, Edward W, Punwani, Shonit, Knight, Bridget, McCullagh, Paul, McGrath, John, Crundwell, Malcolm, Harries, Lorna, Bogdan, Denisa, Westaby, Daniel, Fowler, Gemma, Flohr, Penny, Yuan, Wei, Sharp, Adam, de Bono, Johann, Maitland, Norman J, Wisnovsky, Simon, Bertozzi, Carolyn R, Heer, Rakesh, Guerrero, Ramon Hurtado, Daugaard, Mads, Leivo, Janne, Whitaker, Hayley, Pitteri, Sharon, Wang, Ning, Elliott, David J, Schumann, Benjamin and Munkley, Jennifer (2023) Upregulation of GALNT7 in prostate cancer modifies <i>O</i>-glycosylation and promotes tumour growth. ONCOGENE, 42 (12). pp. 926-937.